This content is from: Sponsored Content

How GSK’s Canada SC hearing unfolded

The Supreme Court of Canada met in January to hear the Canada Revenue Agency's (CRA) appeal and Glaxo­Smith­Kline's (GSK) response in a case about whether the taxpayer paid too much for active pharmaceutical ingredients (API) from a Swiss associated enterprise.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an ITR subscriber? Log in here

Related Content

Instant access to all of our content. Membership Options | One Week Trial

Related